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A common thread among conserved life span regula-
tors lies within intertwined roles in metabolism and
energy homeostasis. We show that heterozygous
mutations of AMP biosynthetic enzymes extend
Drosophila life span. The life span benefit of these
mutations depends upon increased AMP:ATP and
ADP:ATP ratios and adenosine monophosphate-
activated protein kinase (AMPK). Transgenic expres-
sion of AMPK in adult fat body or adult muscle, key
metabolic tissues, extended life span, while AMPK
RNAi reduced life span. Supplementing adenine,
a substrate for AMP biosynthesis, to the diet of
long-lived AMP biosynthesis mutants reversed life
span extension. Remarkably, this simple change in
diet also blocked the prolongevity effects of dietary
restriction. These data establish AMP biosynthesis,
adenosine nucleotide ratios, and AMPK as determi-
nants of adult life span; provide a mechanistic link
between cellular anabolism and energy sensing
pathways; and indicate that dietary adenine manipu-
lations might alter metabolism to influence animal
life span.
INTRODUCTION
Recent dietary and genetic studies have begun to unravel the
cascades that control longevity (Fontana et al., 2010; Libert
et al., 2007; Piper and Bartke, 2008; Sinclair, 2005). What is
becoming clearer is that metabolic tissues and processes
are central components of life span regulation (Artal-Sanz and
Tavernarakis, 2008; Houtkooper et al., 2010; Roberts and
Rosenberg, 2006). Mechanistically, nutrient-sensing pathways
have been identified as a major class of conserved life span
regulators. This group includes caloric restriction, insulin andCellinsulin-like growth factor signaling, and target of rapamycin
signaling (Antosh et al., 2011; Kapahi et al., 2004; Rogina and
Helfand, 2004; Spindler, 2010; Zid et al., 2009).
A central aspect of cellular metabolism and energy homeo-
stasis is the maintenance of adenosine derivatives (e.g., AMP,
ADP, and ATP) at relatively constant levels (Hardie, 2003). ADP
and ATP are formed from AMP (Hardie, 2003). AMP is generated
by two parallel enzymatic processes: the de novo and the
salvage AMP biosynthesis pathways (Rolfes, 2006). Interest-
ingly, cellular adenosine derivative pools are also linked to
organismal longevity. Recent work has uncovered a role for
AMP biosynthesis in yeast chronological life span (Matecic
et al., 2010); however, the mechanism and relevance to multicel-
lular organisms remains unclear. It seems plausible that the role
of AMP in life span may be conserved; in C. elegans, AMP:ATP
ratios appear predictive of life span, and increased AMPK
activity, which can be mediated by concentrations of adenosine
nucleotide derivatives, can delay worm aging (Apfeld et al., 2004;
Curtis et al., 2006; Greer et al., 2007).
Due to the significant human interest in longevity and the
possibility that drugs relevant to such an effect may also regulate
metabolism, a variety of pharmacological approaches have been
undertaken (Minor et al., 2010). These efforts have been
hampered by the relative paucity of identified molecular path-
ways with functionally druggable properties that can extend life
span when altered (Miller et al., 2011;Minor et al., 2011). To iden-
tify additional metabolic processes that regulate life span, we
performed a metabolically targeted forward mutagenic screen
and then analyzed the life span of the mutants. We found that
enzymes that synthesize AMP regulate longevity. Notably, life
span extension occurred when mutations of pathway compo-
nents were present in the heterozygous state, indicating
a dosage-sensitive relationship. Mechanistically, we found that
long-lived heterozygous mutants had increased AMP:ATP and
ADP:ATP ratios. Increased AMP:ATP or ADP:ATP ratios activate
AMPK (Xiao et al., 2011). The long-lived heterozygous mutants
had increased AMPK activity, and inhibiting AMPK in a heterozy-
gous mutant background blocked increased longevity. Notably,
adult- and tissue-specific (fat body or muscle) transgenicMetabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Inc. 101
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activation and extended adult life span, while AMPK RNAi
blunted AMPK activity and life span. Increased AMP:ATP and
ADP:ATP ratios observed in long-lived mutants were restored
by supplementing the diet of adult mutants with adenine. Dietary
adenine feeding also rescued the extended longevity. Remark-
ably, adenine supplementation also blocked the life span benefit
of dietary restriction. Thus, AMP biosynthetic enzymes are
dosage-sensitive adult longevity regulators. In addition, the
results indicate the importance of cellular energy homeostasis
and AMPK signaling as conserved determinants of life span
control that can be manipulated by specific diets.
RESULTS
Adenylosuccinate Synthetase Regulates Life Span
To identify metabolically relevant regulators of life span, we per-
formed sequential screens: first an insertional enhancer trap
designed to target mutations to metabolic tissues and then
longevity analyses (Suh et al., 2008). In brief, we conducted
a minimal promoter GAL4/UAS-GFP reporter F1 enhancer
trap screen to isolate lines with insertions in loci expressed in
tissues intimately involved in metabolism, predominately in the
Drosophila fat body, and also in oenocytes, anterior midgut,
and muscle (Suh et al., 2008). This ‘‘metabolically-enriched’’
collection was then subjected to repeated longevity testing
with a threshold of positive life span extension set to >130% of
control strain life span, present in both male and female flies,
at two temperatures: 25C and 30C. With this tiered method-
ology, we identified ten lines with significantly increased life
span, supporting the notion that metabolic-regulatory tissues
are a rich source of genetic life span control (Suh et al., 2008).
We focused on line F71 because it had one of the longest life
spans of the ten lines identified in our screen and because the
F71 longevity benefit was present in the heterozygous state.
To remove potential second site mutations, avoid background
or modifier effects, and determine whether the increased life
span was present in more than one background, we analyzed
flies after backcrossing F71 > 10 generations into a control
w1118 strain. The life span of isogenic male and female heterozy-
gous F71 mutants was approximately 20% longer than sibling
controls, and the mutants had reduced age-specific mortality
(Figures 1A–1D). Homozygous F71 mutants were larval lethal.
A variety of physical and behavioral traits have been linked to
Drosophila life span benefits (e.g., reduced feeding rates, smaller
body size, inactivity, or decreased fertility); however, none of
these factors appeared to be associated with the life span
benefit conferred by F71 heterozygosity (Figures S1A–S1D).
The mutants had increased activity, which has recently been
associated with the beneficial life span effects of caloric restric-
tion (Katewa et al., 2012). We also examined courtship and
mating, which are known to reduce female and male life span
(Chapman et al., 1995; Cordts and Partridge, 1996). We found
that F71 heterozygotesmay have a slight trend toward increased
mating frequency, possibly due to the reported effects of the red
eye color induced by P-element insertion (Figure S1E) (Reed and
Reed, 1950). We attempted to reduce potential confounds of
mating by analyzing longevity in several settings designed to
normalize courtship andmating frequencies. Female F71 hetero-102 Cell Metabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Inzygotes maintained life span extension when exposed to both
control and F71 heterozygous males (Figure S1F). F71 heterozy-
gous males analyzed in the absence of female exposure were
also long-lived (Figure S1G). We also assessed oxidative stress
responses of controls and F71 heterozygotes. Unlike some
long-lived animals (Broughton et al., 2005; Lin et al., 1998;
Wang et al., 2003), F71 heterozygotes do not have altered resis-
tance to oxidative stress (Figures S1H and S1I). Together, these
results indicate that heterozygous F71 mutants were long-lived
and healthy.
To identify the genomic location of the F71 insertion, we per-
formed 50 and 30 inverse PCR as well as plasmid rescue followed
by DNA sequencing. Sequence alignment of the genomic DNA
flanking the P-element identified a single insertion site in the
third chromosome corresponding to cytogenetic band position
93A1. Drosophila genome database searches revealed that the
F71 P-element inserted into the 50 UTR of the gene CG17273
25 base pairs upstream of the transcriptional start site (Fig-
ure 1E). Sequence similarity searches of the predicted poly-
peptide identified CG17273 as the Drosophila ortholog of
Adenylosuccinate Synthetase (AdSS). To assess the generality
of this gene’s effect on life span, we acquired an
independently derived AdSS insertional mutation, HA2022
(Figure 1E), and backcrossed it over ten generations into w1118.
We evaluated AdSS expression levels with qPCR of adult
extracts and found F71 decreased levels approximately 50%,
while HA2022 diminished expression approximately 27% (Fig-
ure 1F). We then compared the life span of control, F71, and
HA2022 flies and confirmed that females and males heterozy-
gous for either AdSS insertion lived significantly longer than
controls (Figures 1G and 1H). To determine if transgenic expres-
sion of AdSS rescued the F71 heterozygous mutant life span
extension, we generated transgenic flies that contained full-
length AdSS cDNA under the control of an upstream activating
sequence (UAS). Taking advantage of the GAL4 enhancer trap
module contained within the F71 P-element insertion, we deter-
mined whether wild-type AdSS transgenesis, under the control
of endogenous AdSS tissue enhancer elements, rescued the
F71 heterozygous longevity phenotype simply by crossing the
UAS-AdSS allele with F71 heterozygotes. The mortality curves
of UAS-AdSS;;+/+ and UAS-AdSS;;F71/+ siblings showed that
AdSS transgenesis reversed the F71 heterozygous life span
extension (Figures 1I and 1J). The accumulated data support
the notion that AdSS regulates longevity.
AMP Biosynthesis Enzymes Regulate Life Span
AdSS catalyzes the first committed step of de novo AMP biosyn-
thesis (Stayton et al., 1983) (Figure 2). We next evaluated the
possibility that other components of de novo AMP biosynthesis
might also control life span. To test this, we obtained a P-element
insertion located within the Adenylosuccinate Lyase (AdSL)
locus and again backcrossed into w1118. As observed with
the AdSS alleles, male and female flies carrying heterozygous
insertions in AdSL displayed extended longevity, and homozy-
gous mutants died as larvae (Figures 3A and 3B). In addition to
the de novo pathway, AMP can be synthesized via a salvage
pathway (Figure 2). Therefore, we acquired insertional mutations
in two AMP salvage pathway components, Adenosine Kinase
(AdenoK) and Adenine Phosphoribosyltransferase (Aprt), andc.
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B Figure 1. Adenylosuccinate Synthetase
Regulates Life span
(A and B) Heterozygous F71 P-element insertion
extends life span of (A) female and (B) male adult
flies (log rank, p < 0.00001 in either case).
(C and D) Log mortality plots of F71 heterozygous
(A) females and (B) males.
(E) Insertions of F71 and HA2022 in the 50
untranslated region of AdSS.
(F) AdSS expression is reduced in F71 and
HA2022 heterozygotes. Data presented ± SEM
(*p < 0.05, **p < 0.01, Student’s t test).
(G and H) Independently derived AdSS heterozy-
gous insertions, F71 and HA2022, extend life span
of (G) females and (H) males (log rank of any
heterozygote compared to controls, p < 0.008).
(I and J) Transgenic expression of wild-type
AdSS in the F71 heterozygous background
restores life span to that of (I) female and (J) male
controls (log rank of F71 heterozygous to trans-
genic, p < 0.00001; log rank of transgenic to
controls, p = 0.58). Also see Table S1.
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and females heterozygous for insertions in AdenoK or Aprt were
long-lived (Figures 3C–3F).
In addition to the two AMP biosynthesis pathways, Adenylate
Kinase (Adk) also generates AMP by catalyzing the conver-
sion of two molecules of ADP into AMP and ATP. Three homo-
logs of AdK are present in the fly genome, and an insertion,Cell Metabolism 17, 101–112which we backcrossed into w1118, into
Adenylate Kinase 2 (Adk2) was available.
Heterozygous Adk2 mutant males and
females had increased life span (Figures
3G and 3H). We also tested an insertional
mutation of AMP deaminase, which
catalyzes the hydrolytic deamination of
adenosine monophosphate into inosine
monophosphate, the opposite direction
of the longevity genes (Figure 2). Hetero-
zygous insertional mutation of AMP
deaminase had no effect on life span
(Figure 3I). Of note, AMP deaminase is
present on the X chromosome so only
females are able to carry a heterozygous
insertion.
AdSL is a bifunctional enzyme and
participates in inosine monophosphate
(IMP) synthesis prior to AMP-specific
production as well as later, specifically
in the AMP de novo biosynthesis path-
way (Figure 2) (Toth and Yeates,
2000). Aminoimidazolecarboxamide for-
myltransferase (AICAR-ft) also acts prior
to committed AMP biosynthesis to
produce IMP, but unlike AdSL, AICAR-ft
does not function in AMP-specific
biosynthesis pathways (Figure 2). IMP is
a substrate for both AMP and guanosine
monophosphate (GMP) production (Fig-ure 2). To attempt to probe this bifurcation—that is, whether
the role of AdSL in longevity was due to IMP or AMP biosyn-
thesis—we examined an AICAR-ft insertional mutant. Heterozy-
gous insertional mutation of AICAR-ft had no effect on life span
(Figures 3J and 3K). Of note, all heterozygous mutants examined
had between 25% and 50% reduced transcript expression of
their respective gene, similar to the reduction in long-lived, January 8, 2013 ª2013 Elsevier Inc. 103
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Figure 2. AMP Biosynthesis Pathways
AMP biosynthesis occurs though two distinct pathways, de novo and salvage.
AdSS catalyzes the first committed step in de novo AMP biosynthesis followed
by the action of AdSL. AMP deaminase (AMP deam) is the reverse of these
two reactions, converting AMP into IMP. The salvage pathway converts
adenine via Aprt or adenosine via AdenoK to AMP. Adk also produces AMP
from ADP substrate molecules. Prior to committed AMP biosynthesis, AdSL
and AICAR-ft sequentially catalyze the final reactions of IMP synthesis. IMP is
a substrate for the synthesis of both AMP and GMP.
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that heterozygous mutations in genes encoding enzymes
committed to the synthesis of adenosine derivatives extend life
span.
AMP Biosynthesis Mutations Alter Adenosine
Nucleotide Ratios
A plausible consequence of mutating components of adenosine
nucleotide synthesis is the altered concentration or ratios of the
products in vivo. Data in worms indicate that the ratios of these
products (e.g., AMP:ATP) might be predictive of life span; for
example, they increase in response to caloric restriction (Apfeld
et al., 2004; Greer et al., 2007). To explore whether this effect
might be conserved, we performed high-performance liquid
chromatography (HPLC) on perchloric acid extracts of adult flies
randomized to either normal feeding or 48 hr of food withdrawal
(‘‘starved’’). We found that AMP and ADP concentrations were
increased in the latter group, while ATP levels were reduced
(Figures 4A–4C). Next we tested the possibility that the AMP
biosynthetic pathways might also regulate AMP, ADP, or ATP
concentration. We found that heterozygous mutants that were
long-lived had increased AMP and ADP and reduced ATP
concentrations, changes similar to those observed with food
withdrawal; however, those with wild-type survival curves (e.g.,
AMP deaminase and AICAR-ft heterozygotes) had quantities
equal to controls (Figures 4A–4C). Transgenic expression of
AdSS in the F71 heterozygous mutant background, which
rescued life span extension (Figures 1I and 1J), also restored
AMP, ADP, and ATP levels (Figures 4A–4C). Of note, no signifi-
cant alterations in total adenosine derivative pools were reached
in any heterozygous mutant (data not shown); however, we
cannot rule out a possible contribution of reduced total adeno-
sine nucleotide derivatives that may escape detection limits.104 Cell Metabolism 17, 101–112, January 8, 2013 ª2013 Elsevier InAMP:ATP and ADP:ATP ratios are key determinants of cellular
energy status and are potent allosteric regulators of the
evolutionarily conserved cellular energy sensor Adenosine
monophosphate-activated protein kinase (AMPK) (Xiao et al.,
2011). To further understand the extent to which these ratios
are influenced by the life span-extending heterozygous AMP
synthesis mutations and to further normalize the HPLC data,
we calculated the AMP:ATP and ADP:ATP ratios. We found
that AMP:ATP ratios were approximately 3- to 4-fold and
ADP:ATP approximately 2-fold higher in heterozygous AMP
synthesis mutants with increased life span, similar to the ratios
observed upon food withdrawal (Figures 4D and 4E). The
ratios of the transgenic rescued flies and the flies with normal
life span were not significantly altered (Figures 4D and 4E,
hatched bars).
AMP Biosynthesis Pathway Mutants have Increased
AMPK Activity and their Longevity Depends on AMPK
Increased AMP:ATP and ADP:ATP ratios, as observed in the
AMP biosynthesis mutants, signal via AMPK to maintain cellular
energy homeostasis (Pan and Hardie, 2002). In this manner,
AMPK senses cellular energy to coordinate enzymes and tran-
scription factors shifting metabolic processes between energy
utilization and energy conservation/generation (Carling, 2004;
Hardie, 2007; Kahn et al., 2005). The increased ratios of
AMP:ATP and ADP:ATP observed in the AMP biosynthetic
pathway longevity mutants indicate that AMPK activity might
be increased in the heterozygous mutants. To test this, we
harvested adult control and F71 heterozygous mutant flies and
probed AMPK activity by examining, the phosphorylation state
of AMPK and its downstream target acetyl-CoA carboxylase
(ACC); extracts of flies that were deprived of food for 48 hr served
as a positive control. We found that levels of AMPK and ACC
phosphorylation were increased in the mutants, supporting the
idea that AMPK was activated (Figures 5A–5D).
To test whether AMPK activity was necessary for the life span
benefit of heterozygous AMP biosynthesis mutants, we used
the GAL4 present in the F71 insertion to drive expression of a
UAS-AMPK dominant-negative allele (UAS-AMPKDN) in AdSS
heterozygous mutants. We found that expression of dominant-
negative AMPK eliminated the life span benefit seen in male
and female F71 heterozygotes (Figures 5E and 5F). These
data indicate that AMPK is activated in the heterozygous AMP
biosynthesis mutants and that the life span extension of the
heterozygotes depends upon AMPK. Further, the observation
that dominant-negative AMPK suppressed the longevity of F71
heterozygous mutants when driven by the GAL4 present in the
F71 locus suggests that the effects of AMP synthesis mutation
on life span determination may act cell autonomously.
Transgenic Activation of AMPK in the Adult Fat Body
or Muscle Increases Life Span
We attempted to further dissect the role of AMPK in life span
control by increasing or decreasing its levels through transgene-
sis. Based upon the tissue- and cell-autonomous necessity of
AMPK in the life span extension of the F71mutant, we first eval-
uated the tissues in which the F71 mutation, and hence AMPK,
might act to regulate life span. For this, we exploited the F71-
GAL4 insertion to drive a UAS-eGFP allele and then examinedc.
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Figure 3. AMP Biosynthesis Enzymes Regulate Life Span
(A and B) Heterozygous insertional mutation of AdSL extends life span of adult (A) female and (B) male flies (log rank, p < 0.00001 in either case).
(C and D) Heterozygous insertions into AMP salvage pathway biosynthesis components (AdenoK) extend (C) female and (D) male life span (log rank of any
heterozygote compared to controls, p% 0.0002).
(E and F) Heterozygous insertions into AMP salvage pathway biosynthesis components (Aprt) extend (E) female and (F) male life span (log rank of any hetero-
zygote compared to controls, p% 0.0002).
(G and H) Heterozygous insertion in Adk2 increases longevity of (G) females and (H) males (log rank, p < 0.004 in either case).
(I) Heterozygous AMP deaminase insertion does not alter life span (log rank, p > 0.8).
(J and K) Heterozygous insertion in AICAR-ft does not alter (J) female or (K) male life span (log rank, p > 0.8 in either case). Also see Table S1.
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larval and adult fat body, muscle, and some in the brain (Fig-
ure S3), tissues that are key regulators of fly and mammalian
metabolism and longevity. These results also provided a subset
of tissues in which to test the hypothesis that AMPK might
regulate life span. We also attempted to explore the notion
that AMPK might govern adult longevity, as dietary restriction
is often tested in adults. So we combined a UAS-AMPKWT or
a UAS-AMPK RNAi (AMPK-RNAi) allele with two different
RU486-inducible GeneSwitch GAL4 lines: fat body (S106
GAL4) or muscle (myosin heavy chain GeneSwitch GAL4,
MHC-GS-GAL4). Then, we randomized adults containing the
appropriate genetic arrangements to vehicle or RU486. Of
note, AMPK transgenesis increased AMPK expression levels
and activity, while AMPK RNAi had the opposite effects (Figures
6A and 6B). We next examined survival and found that adult-
specific expression of AMPK in the fat body or in muscleCellincreased Drosophila life span (Figures 6C and 6D); conversely,
fat body and muscle-specific AMPK RNAi reduced life span
(Figures 6E and 6F). These data indicate that AMPK plays
a conserved role in life span determination in a tissue- and
adult-specific manner. They also support a model in which
heterozygous AMP biosynthesis mutations alter adenine
nucleotide ratios, which in turn activate AMPK, and then lead
to increased longevity.
Adenine Supplementation Restores Adenosine
Nucleotide Ratios and Rescues Longevity Conferred
by AMP Synthesis Mutation or Dietary Restriction
Since AMP biosynthesis can occur through the modification of
adenine via the salvage pathway (Figure 2), we hypothesized
that dietary adenine supplementation might affect adenosine
derivative pools. To identify an appropriate concentration of
adenine, we exploited the larval lethality of mutant AdSS andMetabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Inc. 105
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Figure 4. AMP Biosynthesis Enzymes
Affect Adenosine Nucleotide Derivatives
(A–C) Food deprivation (Starved) and those
heterozygous mutations of AMP biosynthesis
components that increase life span also increase
(A) AMP and (B) ADP and reduce (C) ATP con-
centration compared to controls. AMP deaminase
or AICAR-ft mutations do not affect life span or
adenosine nucleotide concentration. Transgenic
overexpression of wild-type AdSS (black hatched
bar) rescues the alterations observed in F71
heterozygotes. Data presented ± SEM (*p < 0.05,
**p < 0.01, Student’s t test). Throughout the figure,
hatched bars indicate genetic alterations that do
not affect life span.
(D and E) Food deprivation and heterozygous
mutations of AMP biosynthesis components
that increase life span increase (D) AMP:ATP
and (E) ADP:ATP ratios compared to controls.
AMP deaminase or AICAR-ft mutations do not
affect life span or AMP:ATP and ADP:ATP ratios.
Transgenic overexpression of wild-type AdSS
(black hatched bar) rescues the increased
AMP:ATP and ADP:ATP ratios observed in F71
heterozygotes. Data presented ± SEM (*p < 0.05,
**p < 0.01, Student’s t test).
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Figure 5. AMPK Is Activated in the Heterozygous Mutants and Is Required for their Longevity Benefit
(A and B) Food deprivation (Starved) and F71 heterozygous mutation increases (A) AMPK and (B) ACC phosphorylation. Each panel presented is from analysis of
a single blot.
(C and D) ImageJ quantification of increased (C) AMPK and (D) ACC phosphorylation.
(E and F) Dominant negative AMPK (AMPKDN) rescues F71 heterozygous life span extension of (E) females and (F) males (log rank, p > 0.5). Also see Table S1.
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tation rescued the mortality. We found that adding 0.05%
and 0.1% (w/v) adenine to the diet produced Mendelian
ratios of both AdSS and AdSL homozygous pupae (Figure 7A).
Unfortunately, the resulting pupae remained pharate, perhaps
due to the lack of continued adenine consumption during
metamorphosis, which precluded adult life span analysis of
the rescued larvae. To attempt to circumvent this issue, and
also to assess potential adult-specific life span extension, we
supplemented the diet of adult control and F71 heterozygotes
with 0.05% (w/v) adenine, a concentration that rescued
larval lethality. Adenine supplementation restored the ratio of
AMP:ATP and ADP:ATP in F71 heterozygotes to that of unsup-
plemented controls (Figure 7B, not shown). Notably, adenine
addition rescued heterozygous life span extension (Figure 7C).CellAdenine feeding had no effect on control life span, indicating
that the supplementation at this dose was not significantly toxic
(Figure 7C).
The reversal of life span extension of F71 heterozygotes by
dietary adenine suggested that other life span-extending inter-
ventions, particularly those acting through AMPK activation,
might also be influenced by adenine supplementation. In
C. elegans, AMPK is necessary for some caloric restriction
protocols (Apfeld et al., 2004; Greer and Brunet, 2009; Greer
et al., 2007; Mair et al., 2011). It seemed plausible that some of
the life-extending effects of caloric restriction (CR) might be
due to reduced adenine consumption. So we next tested the
effect of adding adenine to the diet of calorie-restricted long-
lived flies. For this, we randomized adult wild-type flies to normal
conditions or dietary restriction (DR) and then subdivided eachMetabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Inc. 107
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Figure 6. Tissue-Specific AMPK Function
Controls Adult Life Span Determination
(A) AMPK or AMPK RNAi transgenesis alters
AMPK transcript levels in the expected manner
(right, ImageJ quantification).
(B) Tissue-specific overexpression of AMPK
increases AMPK phosphorylation, while AMPK
RNAi reduces AMPK phosphorylation (right,
ImageJ quantification).
(C) Adult fat body expression of a wild-type AMPK
(UAS-AMPKWT) via the S106 RU486-inducible
GAL4 driver (S106) extends life span (log rank,
p < 0.00001).
(D) Muscle expression, using the MHC-GS-GAL4
driver, of AMPKWT during adulthood extends life
span (log rank, p < 0.00001).
(E) Adult fat body expression via S106 of an RNAi
allele targeting AMPK reduces life span (log rank,
p < 0.00001).
(F) Adult muscle expression via MHC-GS-GAL4
of an RNAi allele targeting AMPK reduces life
span (log rank, p < 0.00001). Also see Table S1.
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mentation. We found that the dietary adenine supplementation
reduced the longevity benefit of dietary restriction (Figure 7D).
Thus, a single dietary component can regulate adult life span,
in both long-lived AMP biosynthesis mutants and long-lived
calorically restricted flies.
DISCUSSION
Life span is controlled by a complex interaction of genetics and
diet (Fontana et al., 2010; Houtkooper et al., 2010; Libert et al.,
2007; Piper and Bartke, 2008; Sinclair, 2005). Work over the
past few decades has identified caloric restriction and a few
molecular mechanisms as conserved routes to life span exten-
sion (Fontana et al., 2010; Piper andBartke, 2008). The proposed108 Cell Metabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Inc.benefit of increased life span is obvious;
most humans would like to live longer.
Longevity protocols not only increase
life span, but they can also increase
health at old age and delay the onset
and morbidity of disease (Cohen et al.,
2009; Guo et al., 2002; Omodei and Fon-
tana, 2011); that is, they increase life span
and ‘‘health span’’ (Suh et al., 2008). This
indicates that therapeutic strategies to
initiate prolongevity pathways might be
an important goal and could, for example,
increase well-being while reducing
healthcare costs and the need for health-
care access, which are currently major
topics of concern. Both dietary and phar-
maceutical strategies are plausible
methods to affect such benefits.
However, the unpleasantness of mark-
edly reduced caloric intake, a variety of
side-effects, and various barriers to clin-ical trials have precluded widespread use of either modality.
Potential approaches to ameliorate some of these issues include
directed dietary manipulations, demonstration of pathway effec-
tiveness across evolutionary distance, adult specificity, and
characterization of pathway components with adequate drugg-
ability. The latter can include enzymes, especially those with
dosage-sensitive effects.
To uncover potentially novel mechanisms of life span determi-
nation, we generated and screened a collection of metabolically
targeted insertional mutants for life span extension. We found
that biochemical pathways that control AMP biosynthesis
regulate longevity and that life span benefit was observed in
heterozygous mutants. The mechanism of life span extension
involves increased AMP:ATP and ADP:ATP ratios. Although the
increased ratios may seem counterintuitive to the mutations,
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Figure 7. Dietary Adenine Supplementation Blocks Adult Life Span
Extension
(A) Dietary adenine supplementation (0.05% or 0.1% [w/v]) restores expected
Mendelian ratios of homozygous AdSS and AdSL larval mutant lethality. Data
presented ± SEM (*p < 0.05, **p < 0.01, Student’s t test).
(B) Adding 0.05% (w/v) adenine to the diet of adult F71 heterozygotes restores
AMP:ATP ratios to control levels. Data presented ± SEM (*p < 0.05, **p < 0.01,
Student’s t test).
(C) Supplementing the diet of adult F71 heterozygotes with 0.05% (w/v)
adenine rescues life span extension but does not alter control longevity
(log rank, p > 0.3).
(D) Dietary adenine supplementation blocks the life span benefit of dietary
restriction (DR) (log rank of DR compared to all other curves, p < 0.00001; log
rank comparing all other curves, p > 0.1). Also see Table S1.
Cell Metabolism
Adenine, AMP Synthesis, and AMPK Control Life Span
Cellfeedback regulation, impinging mechanisms, and pool mainte-
nance could be underlying. Previous studies in worms and yeast
have been key drivers identifying conserved pathways of life
span extension, such as sirtuin, TOR, and insulin signaling, that
appear functional in mammals (Blu¨her et al., 2003; Harrison
et al., 2009; Kanfi et al., 2012). Studies in these two organisms
also amplify the role of AMP biosynthesis and altered AMP:ATP
and ADP:ATP ratios in longevity. A yeast expression profiling
screen identified many genes important in life span regulation
including purine import and biosynthesis (Matecic et al., 2010).
In worms, AMP:ATP and ADP:ATP ratios are elevated in some
longevity mutants, in response to caloric restriction, and may
be predictive of life span (Apfeld et al., 2004; Curtis et al.,
2006). Thus, our studies indicate conservation across significant
evolutionary distances.
AMPK is amajor, and conserved, sensor and regulator of intra-
cellular energy homeostasis (Pan and Hardie, 2002). Increased
ratios of AMP:ATP and ADP:ATP, such as those present in the
AMP biosynthesis pathway mutants, activate AMPK. In turn,
AMPK orchestrates a host of responses and downstream
targets, including various enzymes and transcription factors, to
allow cells to respond to metabolic challenges, thereby trans-
forming the metabolic state from energy-consuming to energy-
storing and -generating (Carling, 2004; Hardie, 2007; Kahn
et al., 2005). Thus, the increased nucleotide ratios observed in
the AMP biosynthesis longevity mutants led to several testable
hypotheses: (1) was AMPK activated in AMP biosynthesis
heterozygous mutants; (2) might AMPK regulate longevity; (3)
might dietary manipulation of reaction substrates, in our case
adenine, reverse the life span extension of AMP biosynthesis
heterozygous mutants; and (4) might adenine or other small
molecules that are part of AMP biosynthesis (substrates or prod-
ucts), which are plentiful in the diet, play a role in the longevity
associated with caloric restriction?
We performed a series of studies to attempt to dissect
possible roles of AMPK in life span control. First, we examined
the notion that AMPK was activated in long-lived mutant
flies with elevated AMP:ATP and ADP:ATP ratios. We probed
AMPK activity of adult control and heterozygous mutants by
examining phosphorylation levels of relevant substrates using
western blots. Based upon the phosphorylation status of
AMPK and its downstream target ACC, AMPK was activated in
the adult long-lived mutants. We then attempted to extend these
findings, probing the idea that AMPK activity might be more than
just amarker of the altered ratios and perhaps was even required
for the life span benefit observed in the mutant flies. To test this,
we utilized the UAS-GAL4 system inherent to our initial inser-
tional screen to reduce AMPK activity by expressing a domi-
nant-negative form of AMPK in the tissues in which the inser-
tional mutation was expressed. This maneuver reversed the life
span benefit, supporting the concept that AMP biosynthesis
pathway mutant longevity depends on AMPK.
The observations that nucleotide ratios and AMPK activity
were elevated in adult long-lived mutants and also in flies under
starved conditions, a crude surrogate of acute caloric restriction,
and that AMPK activity appeared required for their life span
extension raised the possibility that AMPK might play a more
general role in adult life span control. To attempt to examine
this notion, we transgenically expressed wild-type AMPK orMetabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Inc. 109
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provided both temporal and spatial control. As AMPK can
function in a cell autonomous fashion and because the
UAS-AMPKDN;F71/+ necessity tests indicated that AMPK was
required in the tissues affected by the F71 insertion, we exam-
ined the expression of the insertion. We found strong levels
in larval and adult fat body and muscle. So we focused our
experimentation to these tissues and attempted to increase or
decrease AMPK by combining UAS-AMPKWT and UAS-AMPK
RNAi transgenes with fat body and muscle RU-486-inducible
GAL4 alleles. Notably, adult-specific transgenic expression of
AMPK within tissues strongly expressing AMP biosynthesis
pathway components, fat body and muscle, extended
Drosophila life span, while AMPK RNAi had the opposite effect.
To further dissect the role of AMP biosynthesis in longevity,
we attempted to alter the nucleotide ratios through manipula-
tion of the nucleotide concentration in the diet. As adenine
is a substrate for the AMP biosynthesis salvage pathway, it
seemed a logical choice as a means to restore the ratios in
the de novo pathway mutants. Consistent with this notion,
adenine rescued the larval lethality of the de novo mutants
(e.g., AdSS and AdSL). Using a dose that rescued larval
lethality, we began to probe the ratios in adult AdSS mutant
flies after adenine feeding. We found that adult dietary adenine
supplementation restored the adenosine nucleotide ratio to
that of control flies. Remarkably, the same dose rescued life
span extension, further supporting the possibility that the
altered ratios and the life span extension were mechanistically
linked.
The results that adenine dietary manipulation in mutant adults
was sufficient to control life span harkened to the well-estab-
lished relationship between dietary restriction and longevity.
Further, we found that similar to data in worms, food restriction
altered the ratios of AMP:ATP and in exactly the opposite direc-
tion to that of adenine supplementation. So we examined the
effects of adenine addition to calorie-restricted flies. Remark-
ably, supplementing 0.05% adenine in the food effectively
reversed the longevity benefit associated with dietary restriction.
These data raise the possibility that decreased levels of adenine
derivatives from either dietary consumption or endogenous
synthesis may account for some of the life span benefits
conferred by caloric restriction.
Our observations in flies support the role of AMP biosynthesis,
AMP:ATP and ADP:ATP ratios, and AMPK as life span regulators
that can function across broad evolutionary distances. These
roles appear dosage-sensitive, cell-autonomous, and func-
tional in adults based upon dietary adenine supplementation
and genetic manipulation. These results suggest that inter-
ventions reducing adenine conversion to nucleotides might be
plausible methods to extend life span. It is also possible that
reducing dietary adenine, which may be less arduous than
caloric restriction, might be a new approach. In addition, the
dosage sensitivity and enzymatic nature of de novo and salvage
AMP biosynthesis, and the conserved aspects of adenosine
nucleotide derivatives and life span extension, indicate that
these pathways are potential targets amenable to small-
molecule manipulation and worth continued exploration. AMP
biosynthesis pathway mutants require AMPK for life span exten-
sion, and thus the AMPK pathway represents yet another set of110 Cell Metabolism 17, 101–112, January 8, 2013 ª2013 Elsevier Intargets that might be relevant. AMPK activation is known to
produce beneficial effects in disease states, e.g., increase
glucose uptake in people with type 2 diabetes, and clinically
approved AMPK agonists are currently prescribed. Our data
indicate that AMPK activation produces life span extension in
a conserved manner. Furthermore, we demonstrate that AMPK
activation within specific tissues during adulthood is sufficient
for longevity. Taken together, our data support potential dietary
and therapeutic interventions that may extend life span as well
as improve health span.EXPERIMENTAL PROCEDURES
Fly Stocks and Culture
Flies were reared under uncrowded conditions in standard cornmeal dextrose-
agar-yeast media with yeast granules unless otherwise noted. All lines
involved in the enhancer trap screen are as described (Suh et al., 2008). The
location of the P-insertion site for F71 was determined by inverse PCR and
plasmid rescue. The additional AdSS insertional line, HA2022 (P{RS5}
CG17273[5-HA-2022]), was obtained from the Drosophila Genetic Resource
Center. AdSL (PBac{w[+mC] = PB}CG3590[c02781]/TM6B,Tb1), AdenoK (P
{w[+mC] y[+mDint2] = EPgy2}CG11255[EY07694]), Aprt (ru[1] Aprt[5] h[1]),
and AMP deaminase (P{w[+mC] = EPg}CG32626[HP10734]) lines were ob-
tained from the Bloomington Stock Center. Adk2 (P{EP)Adk2[EP2149]) was
obtained from the Exelixis Collection at Harvard Medical School. All lines
were backcrossed at least ten generations into w1118, which was used as
the control unless otherwise noted. MHC-GS-GAL4 was generously provided
by T. Osterwalder (Osterwalder et al., 2001). The fat body-inducible GAL4
driver was obtained from Bloomington Stock Center (Roman et al., 2001).
The UAS-AMPKWT allele was a gift from J. Chung (Lee et al., 2007). UAS-
AMPK-RNAi (v106200) was obtained from the ViennaDrosophilaRNAi Center.Transgenic Flies
Full-length AdSS cDNA was PCR amplified and cloned into pUAST from the
cDNA clone RE23826 to generate pUAST-AdSS. Transgenic lines harboring
pUAST-AdSS were generated using P-element-mediated germline trans-
formation as described previously (Chen and McKearin, 2003; Rubin and
Spradling, 1982). Primer sequences used for PCR amplification and
sequence verification are available upon request. The dominant-negative
AMPK allele, UAS-AMPKDN (P{w[+mC] = UAS-SNF1A.K57A}2), was previ-
ously described (Johnson et al., 2010) and acquired from the Bloomington
Stock Center. The control genotypes for all experiments involving transgenic
flies were the respective UAS allele alone without a GAL4 driver.Life Span Assays
Flies that emerged within a 2-day period were pooled and aged for an addi-
tional 3 days. Approximately 80 males and 80 females were placed in demog-
raphy cages in duplicate or triplicate cohorts per trial. Assays were performed
at room temperature (22C–23C) as described previously (Hwangbo et al.,
2004), and mortality was scored daily when changing to fresh food vials. For
the inducible experiments, the GAL4 (GeneSwitch) was activated in 1- to 2-
day-old adult male or female flies by continuous exposure to medium contain-
ing 200 mM RU486 (Mifepristone, Sigma-Aldrich). For these experiments, flies
on a diet containing only vehicle were used as controls, and fresh medium
was provided every 2 days.RNA Extraction, cDNA Synthesis, and Real-Time PCR
Total RNA from adult males was extracted using TRIzol (Invitrogen), DNase
I-treated, and reverse-transcribed with random hexamers; gene expression
was analyzed using the ABI 7500 Real-Time PCR System.
Data were normalized over endogenous ribosomal protein 49 expression. All
real-time primer sequences were validated for specificity and efficiency prior
to use. Sequences are available upon request.c.
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Adult flies were isolated in sex-specific groups of 40, washed, and placed
on ice. Ice-cold 8% (v/v) HClO4 was added, and samples were immediately
subjected to repeat sonication. The solution was then neutralized with
1 N K2CO3 and centrifuged. The supernatant was passed through a 0.2 mm
filter and subjected to reverse-phase chromatography using a Targa C18
250 3 4.6 mm, 5 mm column as described (Stocchi et al., 1985). Nucleotides
were detected at 254 nm, and peak areas were measured using 32 Karat
Software. Nucleotide identities were confirmed by comigration with known
standards. Food deprived flies were given water for only 48 hr prior to
measurement. Adenine-supplemented flies were given either 0.05% (w/v)
adenine supplemented or control diet (see below) prior to analysis.
Western Blot Analyses
Whole-fly lysates boiled in SDS sample buffer (58.3 mM Tris-HCl [pH 6.8], 6%
glycerol, 0.002%bromophenol blue, 1.7%SDS, and 0.1MDTT) were resolved
by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were
blocked and probed using primary antibodies to phospho-AMPK (Cell
Signaling Technology), phospho-DmACC (Kinasource), total AMPK (Abcam),
total ACC (Pierce) and alpha-tubulin (Cell Signaling Technology). After wash
and incubation with secondary antibody conjugated to horseradish peroxi-
dase (Jackson ImmunoResearch), signals were detected with Amersham
ECL Prime Western Blotting Detection Reagent.
Adenine Supplementation
Standard diet contained approximately 64.2 g cornmeal (MP Biomedicals),
16.0 g dry active yeast (Fleischmann’s), 12.4 g agar (MoorAgar, Inc.),
85.5 ml molasses (Grandma’s Molasses), 8.5 ml Tegosept (240 g/l in ethanol;
Genesee), and 2.4 ml Propionic Acid (Fisher) per liter. Stock solutions of 103
adenine hemisulfate salt (A9126; Sigma-Aldrich) were prepared fresh in ddH2O
(double distilled H2O) with 30% (w/v) autolysed yeast powder (Genesee) and
added in order to avoid additional yeast supplementation. Stock solution
was then added to 55C molten standard diet to generate proper 1X concen-
tration. An equal amount of autolysed yeast solution (without adenine) added
to standard diet was used as control. For larval lethality experiments, progeny
from w1118;;TM6B,Tb1/+, F71/TM6B,Tb1, or AdSL/TM6B,Tb1 adults were
cultured in bottles containing adenine supplemented diet. Percent homozy-
gous pupae was calculated based on the absence of the TM6B,Tb1 balancer
chromosome. Expected survival percentage was calculated after normaliza-
tion to the expected homozygous Mendelian ratio of 1:3. For life span assays,
0.05% adenine-supplemented food was prepared fresh twice throughout
the experiment and stored at 4C.
Dietary Restriction
Control diet contained approximately 160 g (16%) yeast, 110 g sucrose, 52 g
cornmeal, 8 g agar, 1.8 ml tegosept, and 5 ml propionic acid per liter.
Restricted diet maintained control composition, save reduction to 4% yeast.
Adenine supplementation was achieved through addition of a stock solution
to 0.05%. Three replicates were performed.
Statistical Analyses
Log rank tests were performed for survival curves. Differences between
experimental and control groups were assessed using Student’s unpaired
t test. Statistical significance was determined at a value of p < 0.05 or p <
0.01 and is denoted with a single or double asterisk, respectively. Error bars
represent SEM.
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